Brikenstein N, Birenboim M, Kenigsbuch D, Shimshoni J
Med Cannabis Cannabinoids. 2024; 7(1):111-118.
PMID: 39015609
PMC: 11249524.
DOI: 10.1159/000539192.
Rieck S, Kilgus S, Meyer J, Huang H, Zhao L, Matthey M
Arterioscler Thromb Vasc Biol. 2021; 41(12):2974-2989.
PMID: 34615374
PMC: 8608012.
DOI: 10.1161/ATVBAHA.121.316973.
Negus S
Pharmacol Rev. 2019; 71(2):225-266.
PMID: 30898855
PMC: 6448246.
DOI: 10.1124/pr.118.017210.
Baron E, Lucas P, Eades J, Hogue O
J Headache Pain. 2018; 19(1):37.
PMID: 29797104
PMC: 5968020.
DOI: 10.1186/s10194-018-0862-2.
Ratano P, Palmery M, Trezza V, Campolongo P
Front Pharmacol. 2017; 8:200.
PMID: 28446875
PMC: 5388693.
DOI: 10.3389/fphar.2017.00200.
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Leitl M, Negus S
Behav Pharmacol. 2015; 27(4):364-76.
PMID: 26588213
PMC: 4842121.
DOI: 10.1097/FBP.0000000000000207.
Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.
Walter C, Oertel B, Felden L, Kell C, Noth U, Vermehren J
Neuropsychopharmacology. 2015; 41(6):1659-69.
PMID: 26514581
PMC: 4832029.
DOI: 10.1038/npp.2015.336.
Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.
You H, Gadotti V, Petrov R, Zamponi G, Diaz P
Mol Pain. 2011; 7:89.
PMID: 22093952
PMC: 3250956.
DOI: 10.1186/1744-8069-7-89.
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.
Benamar K, Yondorf M, Geller E, Eisenstein T, Adler M
Br J Pharmacol. 2009; 157(7):1225-31.
PMID: 19558543
PMC: 2743841.
DOI: 10.1111/j.1476-5381.2009.00285.x.
Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test.
Barbano M, Castane A, Martin-Garcia E, Maldonado R
Psychopharmacology (Berl). 2009; 205(3):475-87.
PMID: 19452141
DOI: 10.1007/s00213-009-1557-9.
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
Ellis R, Toperoff W, Vaida F, Van Den Brande G, Gonzales J, Gouaux B
Neuropsychopharmacology. 2008; 34(3):672-80.
PMID: 18688212
PMC: 3066045.
DOI: 10.1038/npp.2008.120.
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.
Manzanares J, Julian M, Carrascosa A
Curr Neuropharmacol. 2008; 4(3):239-57.
PMID: 18615144
PMC: 2430692.
DOI: 10.2174/157015906778019527.
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Hamamoto D, Giridharagopalan S, Simone D
Eur J Pharmacol. 2007; 558(1-3):73-87.
PMID: 17250825
PMC: 1995024.
DOI: 10.1016/j.ejphar.2006.11.062.
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.
Pertwee R
AAPS J. 2005; 7(3):E625-54.
PMID: 16353941
PMC: 2751266.
DOI: 10.1208/aapsj070364.
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham S, Angus J, Tudor E, Wright C
Br J Pharmacol. 2005; 144(6):875-84.
PMID: 15778704
PMC: 1576059.
DOI: 10.1038/sj.bjp.0706045.
[Cannabinoids--signal transduction and mode of action].
Rukwied R, Gauter B, Schley M, Konrad C
Schmerz. 2004; 19(6):528-34.
PMID: 15549420
DOI: 10.1007/s00482-004-0349-8.
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G, Goldberg S
Psychopharmacology (Berl). 2003; 169(2):115-34.
PMID: 12827346
DOI: 10.1007/s00213-003-1485-z.
Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys.
Justinova Z, Tanda G, Redhi G, Goldberg S
Psychopharmacology (Berl). 2003; 169(2):135-40.
PMID: 12827345
DOI: 10.1007/s00213-003-1484-0.
Drug interactions with patient-controlled analgesia.
Lotsch J, Skarke C, Tegeder I, Geisslinger G
Clin Pharmacokinet. 2002; 41(1):31-57.
PMID: 11825096
DOI: 10.2165/00003088-200241010-00004.
How might cannabinoids influence sexual behavior?.
Stella N
Proc Natl Acad Sci U S A. 2001; 98(3):793-5.
PMID: 11158546
PMC: 33368.
DOI: 10.1073/pnas.98.3.793.